|
Exhibit No.
|
Exhibit
|
|
|
101.INS
|
Inline XBRL Instance Document.
|
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
Allot Ltd.
|
|
|
|
|
|
|
September 30, 2025
|
By:
|
/s/ Liat Nahum
|
|
|
|
Liat Nahum
|
|
|
|
Chief Financial Officer
|
Page |
|
3-4 |
|
5 |
|
6 |
|
7-8 |
|
9-20 |
| June 30, | December 31, | |||||||
|
2025
|
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
26,943
|
$
|
16,142
|
||||
|
Restricted deposits
|
501
|
904
|
||||||
|
Short-term bank deposits
|
11,050
|
15,250
|
||||||
|
Available-for-sale marketable securities
|
11,518
|
26,470
|
||||||
|
Trade receivables, net (net of allowance for credit losses $ 22,392 and $25,306 on June 30, 2025 and December 31, 2024, respectively)
|
20,135
|
16,482
|
||||||
|
Other receivables and prepaid expenses
|
8,641
|
6,317
|
||||||
|
Inventories
|
8,505
|
8,611
|
||||||
|
Total current assets
|
87,293
|
90,176
|
||||||
|
NON-CURRENT ASSETS:
|
||||||||
|
Severance pay fund
|
243
|
464
|
||||||
|
Restricted deposit
|
329
|
279
|
||||||
|
Available-for-sale marketable securities
|
21,672
|
-
|
||||||
|
Operating lease right-of-use assets
|
6,091
|
6,741
|
||||||
|
Other assets
|
552
|
2,151
|
||||||
|
Property and equipment, net
|
6,039
|
7,692
|
||||||
|
Intangible assets, net
|
-
|
305
|
||||||
|
Goodwill
|
31,833
|
31,833
|
||||||
|
Total non-current assets
|
66,759
|
49,465
|
||||||
|
Total assets
|
$
|
154,052
|
$
|
139,641
|
||||
| June 30, | December 31, | |||||||
|
2025
|
2024
|
|||||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
$
|
924
|
$
|
946
|
||||
|
Employees and payroll accruals
|
8,780
|
8,208
|
||||||
|
Deferred revenues
|
20,647
|
17,054
|
||||||
|
Short-term operating lease liabilities
|
484
|
562
|
||||||
|
Other payables and accrued expenses
|
10,996
|
9,200
|
||||||
|
Total current liabilities
|
41,831
|
35,970
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Deferred revenues
|
6,079
|
7,136
|
||||||
|
Long-term operating lease liabilities
|
5,611
|
5,807
|
||||||
|
Accrued severance pay
|
814
|
946
|
||||||
|
Convertible debt
|
-
|
39,973
|
||||||
|
Total long-term liabilities
|
12,504
|
53,862
|
||||||
|
SHAREHOLDERS' EQUITY:
|
||||||||
|
Share capital -
|
||||||||
|
Ordinary shares of NIS 0.1 par value - Authorized: 200,000,000 shares at June 30, 2025, and December 31, 2024; Issued: 47,290,301 and 40,346,993 shares at June 30, 2025 and December 31, 2024, respectively; Outstanding: 46,474,301 and 39,530,993 shares at June 30, 2025 and December 31, 2024, respectively.
|
1,216
|
1,012
|
||||||
|
Additional paid-in capital
|
367,190
|
318,138
|
||||||
|
Treasury share at cost - 816,000 shares at June 30, 2025 and December 31, 2024.
|
(3,998
|
)
|
(3,998
|
)
|
||||
|
Accumulated other comprehensive income
|
3,030
|
357
|
||||||
|
Accumulated deficit
|
(267,721
|
)
|
(265,700
|
)
|
||||
|
Total shareholders' equity
|
99,717
|
49,809
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
154,052
|
$
|
139,641
|
||||
|
Six Months Ended
|
||||||||
|
June 30,
|
||||||||
|
|
2025
|
2024
|
||||||
|
Revenues
|
||||||||
|
Products
|
$
|
14,040
|
$
|
16,759
|
||||
|
Services
|
33,161
|
27,295
|
||||||
|
Total revenues
|
47,201
|
44,054
|
||||||
|
|
||||||||
|
Cost of revenues
|
||||||||
|
Products
|
6,136
|
5,788
|
||||||
|
Services
|
7,687
|
7,993
|
||||||
|
Total cost of revenues
|
13,823
|
13,781
|
||||||
|
Gross profit
|
33,378
|
30,273
|
||||||
|
|
||||||||
|
Operating expenses:
|
||||||||
|
Research and development costs (net of grant participations of $ 68 and $ 281 for the six months ended June 30, 2025, and 2024, respectively)
|
13,252
|
14,475
|
||||||
|
Sales and marketing
|
14,599
|
15,701
|
||||||
|
General and administrative
|
6,643
|
6,206
|
||||||
|
Total operating expenses
|
34,494
|
36,382
|
||||||
|
|
||||||||
|
Operating loss
|
(1,116
|
)
|
(6,109
|
)
|
||||
|
Loss from extinguishment
|
(1,410
|
)
|
-
|
|||||
|
Other income
|
100
|
-
|
||||||
|
Financial income, net
|
1,033
|
1,029
|
||||||
|
|
||||||||
|
Loss before income tax expenses
|
(1,393
|
)
|
(5,080
|
)
|
||||
|
Income tax expenses
|
628
|
786
|
||||||
|
|
||||||||
|
Net loss
|
$
|
(2,021
|
)
|
$
|
(5,866
|
)
|
||
|
|
||||||||
| Net loss per share: | ||||||||
|
Basic and diluted
|
$
|
(0.05
|
)
|
$
|
(0.16
|
)
|
||
|
|
||||||||
| Weighted average number of shares used in per share computations of net loss: | ||||||||
|
Basic and diluted
|
39,944,413
|
38,562,065
|
||||||
|
|
||||||||
|
Unrealized gain (loss) on available-for-sale marketable securities
|
107
|
(10
|
)
|
|||||
|
Total comprehensive profit (loss) from available-for-sale marketable securities
|
107
|
(10
|
)
|
|||||
|
Unrealized gain (loss) on foreign currency cash flow hedges transactions
|
3,108
|
(583
|
)
|
|||||
|
Net amount reclassified to earnings from hedging transactions
|
(542
|
)
|
(108
|
)
|
||||
|
Total comprehensive profit (loss) from hedge transactions
|
2,566
|
(691
|
)
|
|||||
|
Total other comprehensive profit (loss)
|
2,673
|
(701
|
)
|
|||||
|
Total comprehensive profit (loss)
|
652
|
(6,567
|
)
|
|||||
|
Ordinary shares
|
Additional
paid-in capital
|
Treasury share
|
Accumulated other
comprehensive income (loss)
|
Accumulated deficit
|
Total
shareholders' equity
|
|||||||||||||||||||||||
|
Outstanding shares
|
Amount
|
|||||||||||||||||||||||||||
|
Balance as of December 31, 2024
|
39,530,993
|
1,012
|
318,138
|
(3,998
|
)
|
357
|
(265,700
|
)
|
49,809
|
|||||||||||||||||||
|
Issuance of share capital
|
5,000,000
|
184
|
46,404
|
-
|
-
|
-
|
46,588
|
|||||||||||||||||||||
|
Exercise of share options and restricted share units
|
1,943,308
|
20
|
218
|
-
|
-
|
-
|
238
|
|||||||||||||||||||||
|
Share-based compensation
|
-
|
-
|
2,430
|
-
|
-
|
-
|
2,430
|
|||||||||||||||||||||
|
Other comprehensive gain
|
-
|
-
|
-
|
-
|
2,673
|
-
|
2,673
|
|||||||||||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(2,021
|
)
|
(2,021
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2025
|
46,474,301
|
1,216
|
367,190
|
(3,998
|
)
|
3,030
|
(267,721
|
)
|
99,717
|
|||||||||||||||||||
|
Balance as of December 31, 2023
|
38,376,939
|
981
|
312,128
|
(3,998
|
)
|
483
|
(259,831
|
)
|
49,763
|
|||||||||||||||||||
|
Exercise of share options and restricted share units
|
771,067
|
21
|
(21
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
Share-based compensation
|
-
|
-
|
3,547
|
-
|
-
|
-
|
3,547
|
|||||||||||||||||||||
|
Other comprehensive loss
|
-
|
-
|
-
|
-
|
(701
|
)
|
-
|
(701
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(5,866
|
)
|
(5,866
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2024
|
39,148,006
|
1,002
|
315,654
|
(3,998
|
)
|
(218
|
)
|
(265,697
|
)
|
46,743
|
||||||||||||||||||
|
|
Six Months Ended
|
|||||||
|
|
June 30,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
(2,021
|
)
|
(5,866
|
)
|
||||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Depreciation and amortization
|
2,419
|
2,776
|
||||||
|
Share-based compensation
|
2,430
|
3,547
|
||||||
|
Capital loss
|
255
|
-
|
||||||
|
Loss from extinguishment
|
1,410
|
-
|
||||||
|
Other income
|
(100
|
)
|
-
|
|||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Decrease (Increase) in accrued severance pay, net
|
89
|
(165
|
)
|
|||||
|
Decrease in other assets, other receivables and prepaid expenses
|
1,619
|
1,672
|
||||||
|
Decrease in accrued interest and amortization of premium on available-for sale marketable securities
|
(862
|
)
|
(777
|
)
|
||||
|
Decrease in operating leases liability
|
(203
|
)
|
(618
|
)
|
||||
|
Decrease in operating lease right-of-use asset
|
579
|
1,174
|
||||||
|
Increase in trade receivables
|
(3,653
|
)
|
(2,980
|
)
|
||||
|
Decrease in inventories
|
106
|
2,268
|
||||||
|
Increase (Decrease) in trade payables
|
(22
|
)
|
16
|
|||||
|
Increase (Decrease) in employees and payroll accruals
|
573
|
(4,135
|
)
|
|||||
|
Increase in deferred revenues
|
2,536
|
1,965
|
||||||
|
Increase (Decrease) in other payables and accrued expenses
|
914
|
(12
|
)
|
|||||
|
Net cash provided by (used in) operating activities
|
6,069
|
(1,135
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Decrease in restricted deposit
|
353
|
703
|
||||||
|
Investment in short-term bank deposits
|
(15,750
|
)
|
(3,800
|
)
|
||||
|
Withdrawal of short-term bank deposits
|
19,950
|
10,000
|
||||||
|
Purchase of property and equipment
|
(689
|
)
|
(1,386
|
)
|
||||
|
Investment in marketable securitie
|
(55,434
|
)
|
(34,752
|
)
|
||||
|
Proceeds from redemption or sale of marketable securities
|
49,683
|
32,060
|
||||||
|
Proceeds from sale of patent
|
100
|
-
|
||||||
|
Net cash provided by (used in) investing activities
|
(1,787
|
)
|
2,825
|
|||||
|
|
Six Months Ended
|
|||||||
|
|
June 30,
|
|||||||
|
|
2025
|
2024
|
||||||
|
Cash flows from financing activities:
|
||||||||
|
Issuance of share capital
|
37,691
|
-
|
||||||
|
Proceeds from exercise of stock options
|
238
|
1
|
||||||
|
Redemption of convertible debt
|
(31,410
|
)
|
-
|
|||||
|
Net cash provided by financing activities
|
6,519
|
1
|
||||||
|
Increase in cash and cash equivalents
|
10,801
|
1,691
|
||||||
|
Cash, cash equivalents at the beginning of the period
|
16,142
|
14,192
|
||||||
|
Cash, cash equivalents at the end of the period
|
$
|
26,943
|
$
|
15,883
|
||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
|
NOTE 1: -
|
ORGANIZATION AND DESCRIPTION OF BUSINESS
|
|
NOTE 2: -
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
| NOTE 2: - |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.)
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
| NOTE 3: - |
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
|
|
June 30, 2025
|
December 31, 2024
|
|||||||||||||||||||||||||||||||
|
Amortized cost
|
Gross unrealized gain
|
Gross unrealized
loss
|
Fair
Value
|
Amortized cost
|
Gross
unrealized
gain
|
Gross unrealized
loss
|
Fair
value
|
|||||||||||||||||||||||||
|
Available-for-sale - matures within one year:
|
||||||||||||||||||||||||||||||||
|
US Governmental debentures
|
11,310
|
-
|
-
|
11,310
|
26,455
|
15
|
-
|
26,470
|
||||||||||||||||||||||||
|
Corporate debentures
|
208
|
-
|
-
|
208
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
11,518
|
-
|
-
|
11,518
|
26,455
|
15
|
-
|
26,470
|
|||||||||||||||||||||||||
|
Available-for-sale - matures after one year through three years:
|
||||||||||||||||||||||||||||||||
|
US Governmental debentures
|
2,514
|
10
|
-
|
2,524
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
Corporate debentures
|
19,036
|
112
|
-
|
19,148
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||
|
21,550
|
122
|
-
|
21,672
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||||||
|
$
|
33,068
|
$
|
122
|
$
|
-
|
$
|
33,190
|
$
|
26,455
|
$
|
15
|
$
|
-
|
$
|
26,470
|
|||||||||||||||||
| NOTE 4: - |
FAIR VALUE MEASUREMENTS
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
| NOTE 4: - |
FAIR VALUE MEASUREMENTS (Cont.)
|
|
As of June 30, 2025
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Available-for-sale marketable securities
|
$
|
-
|
$
|
33,190
|
$
|
-
|
$
|
33,190
|
||||||||
|
Foreign currency derivative contracts
|
-
|
2,909
|
-
|
2,909
|
||||||||||||
|
Liabilities:
|
||||||||||||||||
|
Foreign currency derivative contracts
|
-
|
(135
|
)
|
-
|
(135
|
)
|
||||||||||
|
Total financial net assets
|
$
|
-
|
$
|
35,964
|
$
|
-
|
$
|
35,964
|
||||||||
|
As of December 31, 2024
|
||||||||||||||||
|
Fair value measurements using input type
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Assets:
|
||||||||||||||||
|
Available-for-sale marketable securities
|
$
|
-
|
$
|
26,470
|
$
|
-
|
$
|
26,470
|
||||||||
|
Foreign currency derivative contracts
|
-
|
584
|
-
|
584
|
||||||||||||
|
Liabilities:
|
||||||||||||||||
|
Foreign currency derivative contracts
|
-
|
(224
|
)
|
-
|
(224
|
)
|
||||||||||
|
Total financial net assets
|
$
|
-
|
$
|
26,830
|
$
|
-
|
$
|
26,830
|
||||||||
| NOTE 5: - |
DERIVATIVE INSTRUMENTS
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
| NOTE 5: - |
DERIVATIVE INSTRUMENTS (Cont.)
|
|
June 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
Derivatives Designated as Hedging Instruments
|
||||||||
|
Foreign currency contracts
|
$
|
2,909
|
$
|
342
|
||||
|
Derivatives Not Designated as Hedging Instruments
|
||||||||
|
Foreign currency contracts
|
(135
|
)
|
18
|
|||||
|
Total derivative instruments
|
$
|
2,774
|
$
|
360
|
||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
|
NOTE 5: -
|
DERIVATIVE INSTRUMENTS (Cont.)
|
|
Foreign exchange forward and
|
June 30,
|
December 31,
|
||||||||
|
options contracts
|
Balance sheet
|
2025
|
2024
|
|||||||
|
Fair value of foreign exchange non-designated hedge transactions
|
Other receivables and prepaid expenses
|
$
|
-
|
$
|
18
|
|||||
|
Fair value of foreign exchange non-designated hedge transactions
|
Other payables and accrued expenses
|
(135
|
)
|
-
|
||||||
|
Total derivatives non-designated as hedging instruments
|
$
|
(135
|
)
|
$
|
18
|
|||||
| NOTE 6: - |
INVENTORIES
|
|
June 30,
|
December 31, | |||||||
|
2025
|
2024
|
|||||||
|
Raw materials
|
$
|
565
|
$
|
650
|
||||
|
Finished goods
|
7,940
|
7,961
|
||||||
|
$
|
8,505
|
$
|
8,611
|
|||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
|
NOTE 7: -
|
PROPERTY AND EQUIPMENT, NET
|
|
June 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
Cost:
|
||||||||
|
Lab equipment
|
$
|
12,286
|
$
|
13,011
|
||||
|
Computers and peripheral equipment
|
11,296
|
12,058
|
||||||
|
Office furniture and equipment
|
1,169
|
1,431
|
||||||
|
Leasehold improvements
|
2,883
|
3,094
|
||||||
|
SECaaS equipment
|
7,699
|
7,476
|
||||||
|
35,333
|
37,070
|
|||||||
|
Accumulated depreciation:
|
||||||||
|
Lab equipment
|
11,152
|
10,944
|
||||||
|
Computers and peripheral equipment
|
10,146
|
10,778
|
||||||
|
Office furniture and equipment
|
846
|
588
|
||||||
|
Leasehold improvements
|
1,542
|
1,941
|
||||||
|
SECaaS equipment
|
5,608
|
5,127
|
||||||
|
29,294
|
29,378
|
|||||||
|
Depreciated cost
|
$
|
6,039
|
$
|
7,692
|
||||
| NOTE 8: - |
INTANGIBLE ASSETS, NET
|
| a. |
The following table shows the Company's intangible assets for the periods presented
|
|
June 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
Original Cost:
|
||||||||
|
Technology
|
$
|
10,113
|
$
|
10,113
|
||||
|
Backlog
|
1,877
|
1,877
|
||||||
|
Customer relationships
|
3,592
|
3,592
|
||||||
|
Software license
|
1,651
|
1,651
|
||||||
|
IP R&D
|
3,659
|
3,659
|
||||||
|
$
|
20,892
|
$
|
20,892
|
|||||
|
Accumulated amortization:
|
||||||||
|
Technology
|
$
|
10,113
|
$
|
10,113
|
||||
|
Backlog
|
1,877
|
1,877
|
||||||
|
Customer relationships
|
3,592
|
3,592
|
||||||
|
Software license
|
1,651
|
1,651
|
||||||
|
IP R&D
|
3,659
|
3,354
|
||||||
|
$
|
20,892
|
$
|
20,587
|
|||||
|
Amortized cost
|
$
|
-
|
$
|
305
|
||||
| b. |
Amortization expense for the six months ended June 30, 2025 and 2024, was $305 in each period.
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
|
NOTE 9: -
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
a.
|
Liens and guarantees:
|
|
b.
|
Litigations:
|
| NOTE 10: - |
SHAREHOLDERS' EQUITY
|
| a. |
Company's shares:
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
| NOTE 10: - |
SHAREHOLDERS' EQUITY (Cont.)
|
| b. |
Share option plan:
|
|
Option Outstanding
|
||||||||
|
Number
of shares upon exercise
|
Weighted average exercise price
|
|||||||
|
Balance as of December 31, 2024
|
60,000
|
$
|
5.94
|
|||||
|
Forfeited
|
(20,000
|
)
|
$
|
5.94
|
||||
|
Exercised
|
(40,000
|
)
|
$
|
5.94
|
||||
|
Balance as of June 30, 2025
|
-
|
$
|
-
|
|||||
|
Exercisable at end of year
|
-
|
$
|
-
|
|||||
|
RSUs
|
||||||||
|
Number
of shares upon exercise
|
Weighted average share price
|
|||||||
|
Outstanding at beginning of year
|
3,047,441
|
$
|
2.69
|
|||||
|
Granted
|
1,496,627
|
$
|
6.56
|
|||||
|
Vested
|
(653,313
|
)
|
$
|
3.34
|
||||
|
Forfeited
|
(135,572
|
)
|
$
|
2.48
|
||||
|
Unvested at end of year
|
3,755,183
|
$
|
4.13
|
|||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
| NOTE 10: - |
SHAREHOLDERS' EQUITY (Cont.)
|
| c. |
Private placements:
|
| NOTE 11: - |
TAXES ON INCOME
|
| NOTE 12: - |
GEOGRAPHIC AND SEGMENT INFORMATION
|
|
Six months ended June 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Europe
|
$
|
24,391
|
$
|
16,733
|
||||
|
Asia and Oceania
|
7,865
|
14,095
|
||||||
|
Americas
|
6,760
|
6,385
|
||||||
|
Middle East and Africa
|
8,185
|
6,841
|
||||||
|
$
|
47,201
|
$
|
44,054
|
|||||
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
| NOTE 12: - |
GEOGRAPHIC AND SEGMENT INFORMATION (Cont.)
|
|
Six months ended June 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
1st Customer
|
13
|
%
|
14
|
%
|
||||
|
13
|
%
|
14
|
%
|
|||||
|
June 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
Israel
|
$
|
11,529
|
$
|
13,577
|
||||
|
Other
|
601
|
856
|
||||||
|
$
|
12,130
|
$
|
14,433
|
|||||
|
NOTE 13: -
|
CONVERTIBLE NOTES
|
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
|
NOTE 14: -
|
RELATED PARTIES BALANCES AND TRANSACTIONS
|
|
NOTE 15: -
|
SUBSEQUENT EVENT
|
|
Six Months Ended June 30,
|
||||||||
|
(In USD thousands)
|
||||||||
|
2025
|
2024
|
|||||||
|
Revenues
|
||||||||
|
Products
|
14,040
|
16,759
|
||||||
|
Services
|
33,161
|
27,295
|
||||||
|
Total revenues
|
47,201
|
44,054
|
||||||
|
Cost of revenues:
|
||||||||
|
Products
|
6,136
|
5,788
|
||||||
|
Services
|
7,687
|
7,993
|
||||||
|
Total cost of revenues
|
13,823
|
13,781
|
||||||
|
Gross profit
|
33,378
|
30,273
|
||||||
|
Operating expenses:
|
||||||||
|
Research and development (net of grant participations of $68 and $281 for the six months ended June 30, 2025, and 2024,
respectively)
|
13,252
|
14,475
|
||||||
|
Sales and marketing
|
14,599
|
15,701
|
||||||
|
General and administrative
|
6,643
|
6,206
|
||||||
|
Total operating expenses
|
34,494
|
36,382
|
||||||
|
Operating loss
|
(1,116
|
)
|
(6,109
|
)
|
||||
|
Loss from extinguishment
|
(1,410
|
)
|
–
|
|||||
|
Other income
|
100
|
–
|
||||||
|
Financial income, net
|
1,033
|
1,029
|
||||||
|
Loss before income tax expense
|
(1,393
|
)
|
(5,080
|
)
|
||||
|
Income tax expense
|
628
|
786
|
||||||
|
Net loss
|
(2,021
|
)
|
(5,866
|
)
|
||||